Month: January 2014
A conference that includes all types of neuroendocrine tumor patients including mid-gut ‘noids, Lungnoids, P-Net patients and more. get ready for another fantastic lineup featuring over 20 world class NET experts presenting the information you need to make informed decisions about your health….
Summary: Robert Fine, MD, reported at a press conference held in advance of the 2014 Gastrointestinal Cancers Symposium (GICS), that the chemotherapy combination of capecitabine plus temozolomide either stalled disease progression or shrank tumors in 97% of patients whose disease had…